The Platform Group AG header image

The Platform Group AG

TPG

Equity

ISIN DE000A2QEFA1 / Valor 57796644

Xetra (2026-10-02)
EUR 0.94%

The Platform Group AG
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

The Platform Group AG, established in 2012 by Dr. Dominik Benner, is a prominent European company specializing in software-based platform solutions that facilitate eCommerce for both B2B and B2C markets. Initially launched with the platform schuhe24.de to transition a family shoe store into the online space, the company has since expanded to operate 30 platforms across 25 sectors. These platforms enable retailers and manufacturers to list their products on over 50 online channels, streamlining the eCommerce process by handling content, pricing, delivery, and customs. The Platform Group AG's software solutions are designed to digitize traditional businesses, offering a comprehensive ecosystem that minimizes the effort required from partners while maximizing their online trading capabilities. The company's innovative approach connects analog businesses to the digital marketplace, leveraging a decade of software development to support diverse industries.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (02.09.2026):

The Platform Group AG — Q2 2026 (covering H1 2026): The company reported a strong first half of 2026 with record H1 operating performance: GMV and revenue rose ~21%–23%, adjusted EBITDA increased ~22.5%, consolidated net income was stable, and the equity ratio improved materially to 55.4%. Management confirmed its FY2026 guidance (GMV €1.7bn; net revenue €1.0bn; adjusted EBITDA €70–80m) and announced tighter acquisition, debt-reduction and cost-discipline measures.

Key top-line figures

GMV: €788.6m (+20.9% YoY). Total net revenue: €421.0m (+22.7% YoY). H1 growth was broad-based with Consumer Goods up 29.4% to €281.1m; Freight Goods down 5.0% to €51.6m; Industrial Goods +5.6% to €40.6m; Pharma & Retail +15.6% to €38.2m; Optics & Hearing contributed €9.5m (new).

Profitability

Reported EBITDA: €45.4m (+3.9% YoY). Adjusted EBITDA: €40.8m (+22.5% YoY) — the highest adjusted EBITDA the Group has achieved in a first half. Adjusted EBITDA margin: 9.69% (roughly flat YoY); reported EBITDA margin: 10.78% (down ~1.96 pp vs prior year).

Net income and EPS

Consolidated net income: €33.5m (+0.5% YoY). Earnings per share: €1.34 (down 13.5% YoY), reflecting share-count and other adjustments described in the report.

Cash flow and financing

Operating cash flow: €26.8m (+16.3% YoY). Cash flow from investing activities: -€17.8m (improved vs -€31.3m prior). Cash flow from financing activities: -€11.3m (versus €0.6m prior). Management plans further debt reduction (target net debt / adjusted EBITDA well below 2.0) including loan repayments and bond repurchases.

Balance sheet and liquidity

Total assets: €400.9m. Cash & equivalents: €11.6m (down from €13.9m at YE 2025). Equity: €221.9m (up from €184.0m); equity ratio improved to 55.4% (from 48.4%) — the highest in company history to date.

Operational metrics and M&A

Active customers (LTM): 8.4m (vs 6.2m). Orders in period: 6.2m (vs 5.3m). Average order value: €129 (vs €124). Partners: 17,683 (vs 15,781). Two acquisitions closed in H1 2026; planned acquisition of AEP GmbH remains in process. Management expects fewer acquisitions in 2026 but will exploit attractive targets and may sell 1–2 portfolio companies for active portfolio management.

Segment note and outlook

All five segments contributed positive EBITDA; Freight Goods was the only segment with a slight decline in revenue and earnings and corrective measures are underway. Management confirmed the FY2026 forecast: GMV €1.7bn, net revenue €1.0bn, adjusted EBITDA €70–80m.

Share and market data

Xetra closing price (30 Jun 2026): €1.04; market capitalization: €26.0m. Management highlighted that market valuation lagged operating performance and reiterated focus on profitable, scalable platform expansion.

Summarized from source with an LLMView Source

Key figures

-89.8%1Y
-85.6%3Y
-95.3%5Y

Performance

104%1Y
71.7%3Y
67.3%5Y

Volatility

Market cap

196 M

Market cap (USD)

Daily traded volume (Shares)

243,935

Daily traded volume (Shares)

1 day high/low

7.64 / 7.52

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
4.00
Nature:
starstarstarstarstar
4.00
Amirul Hakim
Malaysia, 18 May 2026
star star star star star
Nice stocks

EQUITIES OF THE SAME SECTOR

Haemonetics Corp
Haemonetics Corp Haemonetics Corp Valor: 937449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.30%USD 104.68
Sanofi SA
Sanofi SA Sanofi SA Valor: 699381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.13%EUR 70.81
EssilorLuxottica SA
EssilorLuxottica SA EssilorLuxottica SA Valor: 497537
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.24%EUR 142.80
Eurofins Scientific SE
Eurofins Scientific SE Eurofins Scientific SE Valor: 58317129
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.43%EUR 74.86
Legend Biotech Corporation
Legend Biotech Corporation Legend Biotech Corporation Valor: 54834759
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.88%USD 18.57
Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals Inc Ionis Pharmaceuticals Inc Valor: 30877188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.05%USD 43.54
Option Care Health Inc
Option Care Health Inc Option Care Health Inc Valor: 52359365
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.27%USD 22.64
HealthEquity Inc
HealthEquity Inc HealthEquity Inc Valor: 24679014
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.75%USD 90.04
Ensign Group Inc
Ensign Group Inc Ensign Group Inc Valor: 3109721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.27%USD 171.78
Sotera Health Company
Sotera Health Company Sotera Health Company Valor: 57897071
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.55%USD 18.22